Literature DB >> 9645345

Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis.

H Yamamura1, H Yoshikawa, M Tatsuta, H Akedo, K Takahashi.   

Abstract

The basic calponin gene is a smooth muscle differentiation-specific gene that encodes an actin-binding protein involved in the regulation of smooth muscle contractility. We studied the expression of the calponin gene in 8 human osteosarcoma cell lines and 17 primary human osteosarcoma tissues by RT-PCR analysis. We also analyzed mRNA expression of smooth muscle-specific genes including SM22alpha, caldesmon and alpha-actin, and for neutral and acidic calponin isoforms. The genes were expressed at various levels by osteosarcoma cell lines and tissues of diverse histological subtypes. The basic calponin protein of an expected size was detected in osteosarcoma cell lines by immunoblot analysis and was localized by immunohistochemistry in the cytoplasm of the tumor cells in osteosarcoma tissues. Survival was found to be significantly increased in patients whose tumors exhibited basic calponin expression, compared with those with no expression. Alterations in the expression of other markers examined were not correlated with prognosis. Our results suggest that the basic calponin gene product may be a novel prognostic variable in patients with osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645345     DOI: 10.1002/(sici)1097-0215(19980619)79:3<245::aid-ijc6>3.0.co;2-p

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.

Authors:  T Ueda; N Araki; M Mano; A Myoui; S Joyama; S Ishiguro; H Yamamura; K Takahashi; I Kudawara; H Yoshikawa
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Vessel size-dependent expression of intermediate-sized filaments, calponin, and h-caldesmon in smooth muscle cells of human coronary arteries.

Authors:  A Nakamura; S Isoyama; K Goto
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

3.  Inhibition of the methyltranferase EZH2 improves aortic performance in experimental thoracic aortic aneurysm.

Authors:  Christian L Lino Cardenas; Chase W Kessinger; Carolyn MacDonald; Arminder S Jassar; Eric M Isselbacher; Farouc A Jaffer; Mark E Lindsay
Journal:  JCI Insight       Date:  2018-03-08

Review 4.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

5.  Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation.

Authors:  Nan Su; Maomao Chen; Siyu Chen; Can Li; Yangli Xie; Ying Zhu; Yaozong Zhang; Ling Zhao; Qifen He; Xiaolan Du; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

6.  Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.

Authors:  Sébastien Salas; Catherine Bartoli; Jean-Laurent Deville; Jean Gaudart; Fréderic Fina; Arlette Calisti; Gérard Bollini; Georges Curvale; Jean-Claude Gentet; Florence Duffaud; Dominique Figarella-Branger; Corinne Bouvier
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

Review 7.  Herpes simplex virus oncolytic therapy for pediatric malignancies.

Authors:  Gregory K Friedman; Joseph G Pressey; Alyssa T Reddy; James M Markert; G Yancey Gillespie
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

8.  Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature.

Authors:  Ping-Pin Zheng; Anieta M Sieuwerts; Theo M Luider; M van der Weiden; Peter A E Sillevis-Smitt; Johan M Kros
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

9.  Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells.

Authors:  Oliver Thompson; Jeelan S Moghraby; Kathryn R Ayscough; Steve J Winder
Journal:  BMC Cell Biol       Date:  2012-01-18       Impact factor: 4.241

10.  Expression of smooth muscle calponin in synovial sarcoma.

Authors:  H Ono; H Yoshikawa; T Ueda; H Yamamura; I Kudawara; M Manou; S Ishiguro; H Funai; Y Koyanagi; N Araki; N Hashimoto; H Sonobe; M Tatsuta; K Takahashi
Journal:  Sarcoma       Date:  1999
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.